Description

Ethyl 2-(6-(4-(Imino(Morpholino)Methyl)Benzamido)Chroman-3-Yl)Acetate (Wxg02940) is a high-purity, advanced pharmaceutical intermediate characterized by its complex molecular architecture incorporating chroman and morpholine moieties. This compound is of significant value for research and development in medicinal chemistry, serving as a critical building block for synthesizing novel therapeutic agents. It is primarily targeted at pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing new drug candidates, particularly in areas requiring sophisticated heterocyclic scaffolds.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders, cardiovascular diseases, or anti-inflammatory pathways.
• Medicinal Chemistry Research: Used as a core scaffold or building block in structure-activity relationship (SAR) studies and lead optimization programs within academic and industrial R&D settings.
• Fine Chemical Synthesis: Employed in multi-step organic synthesis to construct complex molecules for biological evaluation and high-value chemical production.
• Contract Research & Manufacturing (CRAM): Supplied to organizations specializing in custom synthesis and development of active pharmaceutical ingredients (APIs) for clinical trials.
• Chemical Reference Standard: Serves as a high-purity analytical standard for quality control and method development in pharmaceutical analysis.

Basic Information

Item	Details
Product Name	Ethyl 2-(6-(4-(Imino(Morpholino)Methyl)Benzamido)Chroman-3-Yl)Acetate (Wxg02940)
CAS No.	788137-62-2
Molecular Formula	C25H29N3O5
Molecular Weight	451.52 g/mol
Synonyms	WXG02940; Ethyl 2-[6-[[4-(Imino-morpholin-4-ylmethyl)benzoyl]amino]-3,4-dihydro-2H-chromen-3-yl]acetate; 2-(6-(4-(Imino(Morpholino)Methyl)Benzamido)Chroman-3-Yl)Acetic Acid Ethyl Ester; 788137-62-2; Chroman-3-ylacetate derivative; 4-[(E)-N-(morpholin-4-yl)carboximidoyl]benzoic acid 6-(2-ethoxy-2-oxoethyl)-3,4-dihydro-2H-chromen-3-yl ester
EINECS	Contact for details

Quality Control

Our Ethyl 2-(6-(4-(Imino(Morpholino)Methyl)Benzamido)Chroman-3-Yl)Acetate (Wxg02940) is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) detailing all specifications are available upon request, supporting compliance with internal quality protocols and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). This compound may be hygroscopic (moisture-sensitive); therefore, the container should be kept tightly sealed to exclude moisture. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.